ANI PHARMACEUTICALS, INC Increase (Decrease) in Prepaid Expense and Other Assets
ANI PHARMACEUTICALS, INC (ANIP) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$100.93 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2013-05-10
- ANI PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for the quarter ending 2013-03-31 was -$100.93K.
- ANI PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for the quarter ending 2012-12-31 was -$169.44K.
- ANI PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for the quarter ending 2012-09-30 was -$37.31K.
- ANI PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for the quarter ending 2012-06-30 was -$201.69K.
- ANI PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for fiscal 2012 was -$492.67K.
- ANI PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for fiscal 2011 was -$1.68M, a 560.53% decline from fiscal 2010.
- ANI PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for fiscal 2010 was $365.33K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2013-03-31 | -$100.93K 10-Q · filed 2013-05-10 | -$270.37K derived: sum of 2 quarters · filed 2013-05-10 | -$307.68K derived: sum of 3 quarters · filed 2013-05-10 | -$509.37K derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-12-31 | -$169.44K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$206.75K derived: sum of 2 quarters · filed 2013-02-28 | -$408.44K derived: sum of 3 quarters · filed 2013-02-28 | -$492.67K 10-K · filed 2013-02-28 |
| 2012-09-30 | -$37.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$239.00K derived: sum of 2 quarters · filed 2012-11-08 | -$323.23K 10-Q · filed 2012-11-08 | -$465.79K derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-06-30 | -$201.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | -$285.92K 10-Q · filed 2012-08-01 | -$428.48K derived: sum of 3 quarters · filed 2013-05-10 | -$498.08K derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-03-31 | -$84.23K 10-Q · filed 2013-05-10 | -$226.79K derived: sum of 2 quarters · filed 2013-05-10 | -$296.39K derived: sum of 3 quarters · filed 2013-05-10 | -$434.35K derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | -$142.56K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$212.17K derived: sum of 2 quarters · filed 2013-02-28 | -$350.13K derived: sum of 3 quarters · filed 2013-02-28 | -$1.68M 10-K · filed 2013-02-28 |
| 2011-09-30 | -$69.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$207.56K derived: sum of 2 quarters · filed 2012-11-08 | -$1.54M 10-Q · filed 2012-11-08 | -$220.82K derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | -$137.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | -$1.47M 10-Q · filed 2012-08-01 | -$151.22K derived: sum of 3 quarters · filed 2013-02-28 | $8.24K derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | -$1.33M 10-Q · filed 2012-05-08 | -$13.26K derived: sum of 2 quarters · filed 2013-02-28 | $146.20K derived: sum of 3 quarters · filed 2013-02-28 | |
| 2010-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $1.48M derived: sum of 2 quarters · filed 2013-02-28 | $365.33K 10-K · filed 2013-02-28 | |
| 2010-09-30 | $159.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$953.75K 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$1.11M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $30.26K 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |